Table 4.
Regression Analyses
| Outcomes | Predictor | Category | Estimate (95% CI) | p-value |
|---|---|---|---|---|
|
API |
Gender (ref = Female) | Male | −0.04 (−0.63, 0.54) | .88 |
| Race (ref = White) | Minority | 0.78 (0.24, 1.32) | .02 | |
| Cancer System (ref = Breast) | Upper GI | 0.64 (−0.42, 1.70) | .37 | |
| Lower GI | 1.06 (−0.04, 2.17) | .12 | ||
| Reproductive | −0.35 (−1.67, 0.98) | .66 | ||
| Urinary | 0.59 (−0.60, 1.78) | .44 | ||
| Respiratory | 1.02 (−0.03, 2.07) | .12 | ||
| Other | 0.67 (−0.48, 1.82) | .37 | ||
| Age (10 years) | −0.35 (−0.54, −0.15) | .004 | ||
| PPS score (10 points) | −0.32 (−0.58, −0.07) | .04 | ||
| # Comorbidities | 0.03 (−0.07, 0.13) | .64 | ||
|
SDS |
Gender (ref=Female) | Male | −0.50 (−2.80, 1.79) | .67 |
| Race (ref=White) | Minority | −1.62 (−3.74, 0.50) | .26 | |
| Cancer System (ref = Breast) | Upper GI | 1.86 (−2.35, 6.06) | .51 | |
| Lower GI | 3.21 (−1.17, 7.59) | .26 | ||
| Reproductive | 1.99 (−3.16, 7.13) | .54 | ||
| Urinary | 1.36 (−3.35, 6.08) | .62 | ||
| Respiratory | 3.13 (−1.03, 7.28) | .26 | ||
| Other | 2.75 (−1.77, 7.27) | .35 | ||
| Age (10 years) | −1.44 (−2.22, −0.66) | .002 | ||
| PPS score (10 points) | −0.80 (−1.79, 0.20) | .26 | ||
| # Comorbidities | 0.51 (0.12, 0.90) | .046 | ||
| Step 3 Opioid | Age (10 years) | −0.10 (−0.14, −0.06) | <.001 | |
| API | 0.05 (0.02, 0.08) | <.001 | ||
Note: API: Average Pain Intensity; ref: reference category; GI: gastrointestinal;
PPS: Palliative Performance Scale; SDS: Symptom Distress Scale;
Step 3 Opioid: e.g., morphine, hydromorphone, fentanyl; CI: confidence interval